Sequential therapy of metastatic urothelial cancer with monomethyl auristatin E (MMAE)-containing antibody-drug conjugates for different targets
This result showed the therapeutic potential of sequential use of ADC containing the same chemotherapeutic reagents with different targets for metastatic urothelial cancer.
Authors
- Jiaping Yang (ORCID: https://orcid.org/0009-0009-2387-4572)
- Sheng Zhang (ORCID: https://orcid.org/0000-0002-0109-6951)
- Zhiyong Ma (ORCID: https://orcid.org/0000-0003-1720-9866)
- Mingjuan Sun
- Wen Jie Sun
Institutions
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- Tumori Journal
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1177/03008916251362021
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00